Lattice Biologics Ltd. (LBLTF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025

Lattice Biologics Revenue

Lattice Biologics had revenue of $1.56M in the twelve months ending June 30, 2021, down -28.89% year-over-year. In the fiscal year ending September 30, 2020, Lattice Biologics had annual revenue of $2.46M with 12.60% growth.

Revenue (ttm)
1.56M
Revenue Growth
-28.89%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
128.00

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20202.46M275.71K12.60%
Sep 30, 20192.19M1.03M89.49%
Sep 30, 20181.16M-1.58M-57.84%
Sep 30, 20172.74M-1.04M-27.49%
Sep 30, 20163.78M-410.28K-9.80%
Sep 30, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Wellness Center USA 391.24K
Zecotek Photonics 141.07K
ViewRay Systems 105.86M
Brain Scientific 214.56K
BIOLASE 46.03M
Lombard Medical 12.17M
Enchanted World 303.00K
Motus GI Holdings 327.00K
Revenue Rankings